FMT
KALV

First Mercantile Trust’s KalVista Pharmaceuticals KALV Stock Holding History

First Mercantile Trust’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$43K Sell
2,457
-203
-8% -$4.11K 0.01% 787
2021
Q2 		$64K Buy
2,660
+815
+44% +$21.3K 0.01% 770
2021
Q1 		$47K Buy
+1,845
New +$48.5K 0.01% 784

Other funds holding KALV

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Mercantile Trust's KALV Position: Q3 2021 in Review

First Mercantile Trust reduced its KalVista Pharmaceuticals (KALV) stake by 7.6% in Q3 2021, selling an estimated $4.11K and leaving 2,457 shares worth $43K. The position accounts for 0.01% of the portfolio, ranked #787.

First Mercantile Trust first reported a position in KALV in Q1 2021 and has held it in 3 quarters since. The position peaked at $64K in Q2 2021. 105 funds tracked by Wall St. Rank hold KALV as of Q3 2021.

  • First Mercantile Trust held 2,457 shares of KalVista Pharmaceuticals worth $43K as of Q3 2021.
  • First Mercantile Trust sold 203 KalVista Pharmaceuticals shares in Q3 2021, an estimated $4.11K.
  • KalVista Pharmaceuticals made up 0.01% of First Mercantile Trust's portfolio in Q3 2021, its #787 holding.
  • First Mercantile Trust first reported a position in KalVista Pharmaceuticals in Q1 2021 and has held it in 3 quarters since.
  • First Mercantile Trust's KalVista Pharmaceuticals position peaked at $64K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.